| abstract |
The invention relates to medicine, veterinary since and biotechnology and can be used for producing a curing preparation for medicine and veterinary purposes. The inventive bacteriolytic complex is produced by a Xanthomonas campestris XLI bacteria (the strain is deposited under number BKM B-2249 D) which contains bacteriolytic enzymes (muramidase, myramoylalanine amidase, endopeptidase, bacteriolytic ferment having a molecular mass close to 22 kDa), protease, polysaccharide and ballast agents. The inventive method for producing said bacteriolytic complex consists in cultivating a strain-product with the aid of a nutritive medium, Said nutritive medium contains glucose, peptone, yestrel or autolysis yeast, sodium and potassium phosphates, magnesium sulphate, potassium chloride, ferrum sulphate and water. |